Global Cyclophosphamide Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Cyclophosphamide market size is predicted to grow from US$ 656 million in 2025 to US$ 747 million in 2031; it is expected to grow at a CAGR of 2.2% from 2025 to 2031.
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Top 8 manufacturers took 75.4% market share in 2019.
LP Information, Inc. (LPI) ' newest research report, the “Cyclophosphamide Industry Forecast” looks at past sales and reviews total world Cyclophosphamide sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyclophosphamide sales for 2025 through 2031. With Cyclophosphamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclophosphamide industry.
This Insight Report provides a comprehensive analysis of the global Cyclophosphamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclophosphamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclophosphamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclophosphamide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclophosphamide.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclophosphamide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cyclophosphamide market?
What factors are driving Cyclophosphamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyclophosphamide market opportunities vary by end market size?
How does Cyclophosphamide break out by Type, by Application?
The global Cyclophosphamide market size is predicted to grow from US$ 656 million in 2025 to US$ 747 million in 2031; it is expected to grow at a CAGR of 2.2% from 2025 to 2031.
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Top 8 manufacturers took 75.4% market share in 2019.
LP Information, Inc. (LPI) ' newest research report, the “Cyclophosphamide Industry Forecast” looks at past sales and reviews total world Cyclophosphamide sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyclophosphamide sales for 2025 through 2031. With Cyclophosphamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclophosphamide industry.
This Insight Report provides a comprehensive analysis of the global Cyclophosphamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclophosphamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclophosphamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclophosphamide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclophosphamide.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclophosphamide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- High-Dose
- Low-Dose
- Cancer
- Autoimmune Diseases
- AL Amyloidosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- Novartis
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals LLC
- Jiangsu Hengrui Medicine
- NorthStar Rx LLC
- GLS Pharma
- CSC Pharmaceuticals International
What is the 10-year outlook for the global Cyclophosphamide market?
What factors are driving Cyclophosphamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyclophosphamide market opportunities vary by end market size?
How does Cyclophosphamide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyclophosphamide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cyclophosphamide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cyclophosphamide by Country/Region, 2020, 2024 & 2031
2.2 Cyclophosphamide Segment by Type
2.2.1 High-Dose
2.2.2 Low-Dose
2.3 Cyclophosphamide Sales by Type
2.3.1 Global Cyclophosphamide Sales Market Share by Type (2020-2025)
2.3.2 Global Cyclophosphamide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cyclophosphamide Sale Price by Type (2020-2025)
2.4 Cyclophosphamide Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 AL Amyloidosis
2.4.4 Others
2.5 Cyclophosphamide Sales by Application
2.5.1 Global Cyclophosphamide Sale Market Share by Application (2020-2025)
2.5.2 Global Cyclophosphamide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cyclophosphamide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Cyclophosphamide Breakdown Data by Company
3.1.1 Global Cyclophosphamide Annual Sales by Company (2020-2025)
3.1.2 Global Cyclophosphamide Sales Market Share by Company (2020-2025)
3.2 Global Cyclophosphamide Annual Revenue by Company (2020-2025)
3.2.1 Global Cyclophosphamide Revenue by Company (2020-2025)
3.2.2 Global Cyclophosphamide Revenue Market Share by Company (2020-2025)
3.3 Global Cyclophosphamide Sale Price by Company
3.4 Key Manufacturers Cyclophosphamide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclophosphamide Product Location Distribution
3.4.2 Players Cyclophosphamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYCLOPHOSPHAMIDE BY GEOGRAPHIC REGION
4.1 World Historic Cyclophosphamide Market Size by Geographic Region (2020-2025)
4.1.1 Global Cyclophosphamide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cyclophosphamide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cyclophosphamide Market Size by Country/Region (2020-2025)
4.2.1 Global Cyclophosphamide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cyclophosphamide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cyclophosphamide Sales Growth
4.4 APAC Cyclophosphamide Sales Growth
4.5 Europe Cyclophosphamide Sales Growth
4.6 Middle East & Africa Cyclophosphamide Sales Growth
5 AMERICAS
5.1 Americas Cyclophosphamide Sales by Country
5.1.1 Americas Cyclophosphamide Sales by Country (2020-2025)
5.1.2 Americas Cyclophosphamide Revenue by Country (2020-2025)
5.2 Americas Cyclophosphamide Sales by Type (2020-2025)
5.3 Americas Cyclophosphamide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclophosphamide Sales by Region
6.1.1 APAC Cyclophosphamide Sales by Region (2020-2025)
6.1.2 APAC Cyclophosphamide Revenue by Region (2020-2025)
6.2 APAC Cyclophosphamide Sales by Type (2020-2025)
6.3 APAC Cyclophosphamide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyclophosphamide by Country
7.1.1 Europe Cyclophosphamide Sales by Country (2020-2025)
7.1.2 Europe Cyclophosphamide Revenue by Country (2020-2025)
7.2 Europe Cyclophosphamide Sales by Type (2020-2025)
7.3 Europe Cyclophosphamide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyclophosphamide by Country
8.1.1 Middle East & Africa Cyclophosphamide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cyclophosphamide Revenue by Country (2020-2025)
8.2 Middle East & Africa Cyclophosphamide Sales by Type (2020-2025)
8.3 Middle East & Africa Cyclophosphamide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclophosphamide
10.3 Manufacturing Process Analysis of Cyclophosphamide
10.4 Industry Chain Structure of Cyclophosphamide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclophosphamide Distributors
11.3 Cyclophosphamide Customer
12 WORLD FORECAST REVIEW FOR CYCLOPHOSPHAMIDE BY GEOGRAPHIC REGION
12.1 Global Cyclophosphamide Market Size Forecast by Region
12.1.1 Global Cyclophosphamide Forecast by Region (2026-2031)
12.1.2 Global Cyclophosphamide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cyclophosphamide Forecast by Type (2026-2031)
12.7 Global Cyclophosphamide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Cyclophosphamide Product Portfolios and Specifications
13.1.3 Baxter Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Cyclophosphamide Product Portfolios and Specifications
13.2.3 Novartis Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Cyclophosphamide Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Amneal Pharmaceuticals LLC
13.4.1 Amneal Pharmaceuticals LLC Company Information
13.4.2 Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolios and Specifications
13.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Amneal Pharmaceuticals LLC Main Business Overview
13.4.5 Amneal Pharmaceuticals LLC Latest Developments
13.5 Jiangsu Hengrui Medicine
13.5.1 Jiangsu Hengrui Medicine Company Information
13.5.2 Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolios and Specifications
13.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jiangsu Hengrui Medicine Main Business Overview
13.5.5 Jiangsu Hengrui Medicine Latest Developments
13.6 NorthStar Rx LLC
13.6.1 NorthStar Rx LLC Company Information
13.6.2 NorthStar Rx LLC Cyclophosphamide Product Portfolios and Specifications
13.6.3 NorthStar Rx LLC Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 NorthStar Rx LLC Main Business Overview
13.6.5 NorthStar Rx LLC Latest Developments
13.7 GLS Pharma
13.7.1 GLS Pharma Company Information
13.7.2 GLS Pharma Cyclophosphamide Product Portfolios and Specifications
13.7.3 GLS Pharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GLS Pharma Main Business Overview
13.7.5 GLS Pharma Latest Developments
13.8 CSC Pharmaceuticals International
13.8.1 CSC Pharmaceuticals International Company Information
13.8.2 CSC Pharmaceuticals International Cyclophosphamide Product Portfolios and Specifications
13.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSC Pharmaceuticals International Main Business Overview
13.8.5 CSC Pharmaceuticals International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Cyclophosphamide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cyclophosphamide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of High-Dose
Table 4. Major Players of Low-Dose
Table 5. Global Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 6. Global Cyclophosphamide Sales Market Share byType (2020-2025)
Table 7. Global Cyclophosphamide Revenue byType (2020-2025) & ($ million)
Table 8. Global Cyclophosphamide Revenue Market Share byType (2020-2025)
Table 9. Global Cyclophosphamide Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Cyclophosphamide Sale by Application (2020-2025) & (Units)
Table 11. Global Cyclophosphamide Sale Market Share by Application (2020-2025)
Table 12. Global Cyclophosphamide Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cyclophosphamide Revenue Market Share by Application (2020-2025)
Table 14. Global Cyclophosphamide Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Cyclophosphamide Sales by Company (2020-2025) & (Units)
Table 16. Global Cyclophosphamide Sales Market Share by Company (2020-2025)
Table 17. Global Cyclophosphamide Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cyclophosphamide Revenue Market Share by Company (2020-2025)
Table 19. Global Cyclophosphamide Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Cyclophosphamide Producing Area Distribution and Sales Area
Table 21. Players Cyclophosphamide Products Offered
Table 22. Cyclophosphamide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyclophosphamide Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Cyclophosphamide Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cyclophosphamide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cyclophosphamide Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cyclophosphamide Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Cyclophosphamide Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cyclophosphamide Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cyclophosphamide Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cyclophosphamide Sales by Country (2020-2025) & (Units)
Table 34. Americas Cyclophosphamide Sales Market Share by Country (2020-2025)
Table 35. Americas Cyclophosphamide Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 37. Americas Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 38. APAC Cyclophosphamide Sales by Region (2020-2025) & (Units)
Table 39. APAC Cyclophosphamide Sales Market Share by Region (2020-2025)
Table 40. APAC Cyclophosphamide Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 42. APAC Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 43. Europe Cyclophosphamide Sales by Country (2020-2025) & (Units)
Table 44. Europe Cyclophosphamide Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 46. Europe Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Cyclophosphamide Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Cyclophosphamide Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 50. Middle East & Africa Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Cyclophosphamide
Table 52. Key Market Challenges & Risks of Cyclophosphamide
Table 53. Key IndustryTrends of Cyclophosphamide
Table 54. Cyclophosphamide Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyclophosphamide Distributors List
Table 57. Cyclophosphamide Customer List
Table 58. Global Cyclophosphamide SalesForecast by Region (2026-2031) & (Units)
Table 59. Global Cyclophosphamide RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cyclophosphamide SalesForecast by Country (2026-2031) & (Units)
Table 61. Americas Cyclophosphamide Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cyclophosphamide SalesForecast by Region (2026-2031) & (Units)
Table 63. APAC Cyclophosphamide Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cyclophosphamide SalesForecast by Country (2026-2031) & (Units)
Table 65. Europe Cyclophosphamide RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cyclophosphamide SalesForecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Cyclophosphamide RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Cyclophosphamide SalesForecast byType (2026-2031) & (Units)
Table 69. Global Cyclophosphamide RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Cyclophosphamide SalesForecast by Application (2026-2031) & (Units)
Table 71. Global Cyclophosphamide RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Baxter Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 73. Baxter Cyclophosphamide Product Portfolios and Specifications
Table 74. Baxter Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Baxter Main Business
Table 76. Baxter Latest Developments
Table 77. Novartis Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Cyclophosphamide Product Portfolios and Specifications
Table 79. Novartis Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Hikma Pharmaceuticals Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 83. Hikma Pharmaceuticals Cyclophosphamide Product Portfolios and Specifications
Table 84. Hikma Pharmaceuticals Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Hikma Pharmaceuticals Main Business
Table 86. Hikma Pharmaceuticals Latest Developments
Table 87. Amneal Pharmaceuticals LLC Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 88. Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolios and Specifications
Table 89. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Amneal Pharmaceuticals LLC Main Business
Table 91. Amneal Pharmaceuticals LLC Latest Developments
Table 92. Jiangsu Hengrui Medicine Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 93. Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolios and Specifications
Table 94. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Jiangsu Hengrui Medicine Main Business
Table 96. Jiangsu Hengrui Medicine Latest Developments
Table 97. NorthStar Rx LLC Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 98. NorthStar Rx LLC Cyclophosphamide Product Portfolios and Specifications
Table 99. NorthStar Rx LLC Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. NorthStar Rx LLC Main Business
Table 101. NorthStar Rx LLC Latest Developments
Table 102. GLS Pharma Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 103. GLS Pharma Cyclophosphamide Product Portfolios and Specifications
Table 104. GLS Pharma Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. GLS Pharma Main Business
Table 106. GLS Pharma Latest Developments
Table 107. CSC Pharmaceuticals International Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 108. CSC Pharmaceuticals International Cyclophosphamide Product Portfolios and Specifications
Table 109. CSC Pharmaceuticals International Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. CSC Pharmaceuticals International Main Business
Table 111. CSC Pharmaceuticals International Latest Developments
LIST OFFIGURES
Figure 1. Picture of Cyclophosphamide
Figure 2. Cyclophosphamide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclophosphamide Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Cyclophosphamide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cyclophosphamide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cyclophosphamide Sales Market Share by Country/Region (2024)
Figure 10. Cyclophosphamide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of High-Dose
Figure 12. Product Picture of Low-Dose
Figure 13. Global Cyclophosphamide Sales Market Share byType in 2025
Figure 14. Global Cyclophosphamide Revenue Market Share byType (2020-2025)
Figure 15. Cyclophosphamide Consumed in Cancer
Figure 16. Global Cyclophosphamide Market: Cancer (2020-2025) & (Units)
Figure 17. Cyclophosphamide Consumed in Autoimmune Diseases
Figure 18. Global Cyclophosphamide Market: Autoimmune Diseases (2020-2025) & (Units)
Figure 19. Cyclophosphamide Consumed in AL Amyloidosis
Figure 20. Global Cyclophosphamide Market: AL Amyloidosis (2020-2025) & (Units)
Figure 21. Cyclophosphamide Consumed in Others
Figure 22. Global Cyclophosphamide Market: Others (2020-2025) & (Units)
Figure 23. Global Cyclophosphamide Sale Market Share by Application (2024)
Figure 24. Global Cyclophosphamide Revenue Market Share by Application in 2025
Figure 25. Cyclophosphamide Sales by Company in 2025 (Units)
Figure 26. Global Cyclophosphamide Sales Market Share by Company in 2025
Figure 27. Cyclophosphamide Revenue by Company in 2025 ($ millions)
Figure 28. Global Cyclophosphamide Revenue Market Share by Company in 2025
Figure 29. Global Cyclophosphamide Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Cyclophosphamide Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Cyclophosphamide Sales 2020-2025 (Units)
Figure 32. Americas Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 33. APAC Cyclophosphamide Sales 2020-2025 (Units)
Figure 34. APAC Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 35. Europe Cyclophosphamide Sales 2020-2025 (Units)
Figure 36. Europe Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Cyclophosphamide Sales 2020-2025 (Units)
Figure 38. Middle East & Africa Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 39. Americas Cyclophosphamide Sales Market Share by Country in 2025
Figure 40. Americas Cyclophosphamide Revenue Market Share by Country (2020-2025)
Figure 41. Americas Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 42. Americas Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 43. United States Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Cyclophosphamide Sales Market Share by Region in 2025
Figure 48. APAC Cyclophosphamide Revenue Market Share by Region (2020-2025)
Figure 49. APAC Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 50. APAC Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 51. China Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 55. India Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Cyclophosphamide Sales Market Share by Country in 2025
Figure 59. Europe Cyclophosphamide Revenue Market Share by Country (2020-2025)
Figure 60. Europe Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 61. Europe Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 62. Germany Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 63.France Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Cyclophosphamide Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 70. Egypt Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Cyclophosphamide in 2025
Figure 76. Manufacturing Process Analysis of Cyclophosphamide
Figure 77. Industry Chain Structure of Cyclophosphamide
Figure 78. Channels of Distribution
Figure 79. Global Cyclophosphamide Sales MarketForecast by Region (2026-2031)
Figure 80. Global Cyclophosphamide Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Cyclophosphamide Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Cyclophosphamide Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Cyclophosphamide Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Cyclophosphamide Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyclophosphamide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cyclophosphamide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cyclophosphamide by Country/Region, 2020, 2024 & 2031
2.2 Cyclophosphamide Segment by Type
2.2.1 High-Dose
2.2.2 Low-Dose
2.3 Cyclophosphamide Sales by Type
2.3.1 Global Cyclophosphamide Sales Market Share by Type (2020-2025)
2.3.2 Global Cyclophosphamide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cyclophosphamide Sale Price by Type (2020-2025)
2.4 Cyclophosphamide Segment by Application
2.4.1 Cancer
2.4.2 Autoimmune Diseases
2.4.3 AL Amyloidosis
2.4.4 Others
2.5 Cyclophosphamide Sales by Application
2.5.1 Global Cyclophosphamide Sale Market Share by Application (2020-2025)
2.5.2 Global Cyclophosphamide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cyclophosphamide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Cyclophosphamide Breakdown Data by Company
3.1.1 Global Cyclophosphamide Annual Sales by Company (2020-2025)
3.1.2 Global Cyclophosphamide Sales Market Share by Company (2020-2025)
3.2 Global Cyclophosphamide Annual Revenue by Company (2020-2025)
3.2.1 Global Cyclophosphamide Revenue by Company (2020-2025)
3.2.2 Global Cyclophosphamide Revenue Market Share by Company (2020-2025)
3.3 Global Cyclophosphamide Sale Price by Company
3.4 Key Manufacturers Cyclophosphamide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclophosphamide Product Location Distribution
3.4.2 Players Cyclophosphamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYCLOPHOSPHAMIDE BY GEOGRAPHIC REGION
4.1 World Historic Cyclophosphamide Market Size by Geographic Region (2020-2025)
4.1.1 Global Cyclophosphamide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cyclophosphamide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cyclophosphamide Market Size by Country/Region (2020-2025)
4.2.1 Global Cyclophosphamide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cyclophosphamide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cyclophosphamide Sales Growth
4.4 APAC Cyclophosphamide Sales Growth
4.5 Europe Cyclophosphamide Sales Growth
4.6 Middle East & Africa Cyclophosphamide Sales Growth
5 AMERICAS
5.1 Americas Cyclophosphamide Sales by Country
5.1.1 Americas Cyclophosphamide Sales by Country (2020-2025)
5.1.2 Americas Cyclophosphamide Revenue by Country (2020-2025)
5.2 Americas Cyclophosphamide Sales by Type (2020-2025)
5.3 Americas Cyclophosphamide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclophosphamide Sales by Region
6.1.1 APAC Cyclophosphamide Sales by Region (2020-2025)
6.1.2 APAC Cyclophosphamide Revenue by Region (2020-2025)
6.2 APAC Cyclophosphamide Sales by Type (2020-2025)
6.3 APAC Cyclophosphamide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyclophosphamide by Country
7.1.1 Europe Cyclophosphamide Sales by Country (2020-2025)
7.1.2 Europe Cyclophosphamide Revenue by Country (2020-2025)
7.2 Europe Cyclophosphamide Sales by Type (2020-2025)
7.3 Europe Cyclophosphamide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyclophosphamide by Country
8.1.1 Middle East & Africa Cyclophosphamide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cyclophosphamide Revenue by Country (2020-2025)
8.2 Middle East & Africa Cyclophosphamide Sales by Type (2020-2025)
8.3 Middle East & Africa Cyclophosphamide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclophosphamide
10.3 Manufacturing Process Analysis of Cyclophosphamide
10.4 Industry Chain Structure of Cyclophosphamide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclophosphamide Distributors
11.3 Cyclophosphamide Customer
12 WORLD FORECAST REVIEW FOR CYCLOPHOSPHAMIDE BY GEOGRAPHIC REGION
12.1 Global Cyclophosphamide Market Size Forecast by Region
12.1.1 Global Cyclophosphamide Forecast by Region (2026-2031)
12.1.2 Global Cyclophosphamide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cyclophosphamide Forecast by Type (2026-2031)
12.7 Global Cyclophosphamide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Cyclophosphamide Product Portfolios and Specifications
13.1.3 Baxter Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Cyclophosphamide Product Portfolios and Specifications
13.2.3 Novartis Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Cyclophosphamide Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Amneal Pharmaceuticals LLC
13.4.1 Amneal Pharmaceuticals LLC Company Information
13.4.2 Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolios and Specifications
13.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Amneal Pharmaceuticals LLC Main Business Overview
13.4.5 Amneal Pharmaceuticals LLC Latest Developments
13.5 Jiangsu Hengrui Medicine
13.5.1 Jiangsu Hengrui Medicine Company Information
13.5.2 Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolios and Specifications
13.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jiangsu Hengrui Medicine Main Business Overview
13.5.5 Jiangsu Hengrui Medicine Latest Developments
13.6 NorthStar Rx LLC
13.6.1 NorthStar Rx LLC Company Information
13.6.2 NorthStar Rx LLC Cyclophosphamide Product Portfolios and Specifications
13.6.3 NorthStar Rx LLC Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 NorthStar Rx LLC Main Business Overview
13.6.5 NorthStar Rx LLC Latest Developments
13.7 GLS Pharma
13.7.1 GLS Pharma Company Information
13.7.2 GLS Pharma Cyclophosphamide Product Portfolios and Specifications
13.7.3 GLS Pharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 GLS Pharma Main Business Overview
13.7.5 GLS Pharma Latest Developments
13.8 CSC Pharmaceuticals International
13.8.1 CSC Pharmaceuticals International Company Information
13.8.2 CSC Pharmaceuticals International Cyclophosphamide Product Portfolios and Specifications
13.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CSC Pharmaceuticals International Main Business Overview
13.8.5 CSC Pharmaceuticals International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Cyclophosphamide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cyclophosphamide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of High-Dose
Table 4. Major Players of Low-Dose
Table 5. Global Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 6. Global Cyclophosphamide Sales Market Share byType (2020-2025)
Table 7. Global Cyclophosphamide Revenue byType (2020-2025) & ($ million)
Table 8. Global Cyclophosphamide Revenue Market Share byType (2020-2025)
Table 9. Global Cyclophosphamide Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Cyclophosphamide Sale by Application (2020-2025) & (Units)
Table 11. Global Cyclophosphamide Sale Market Share by Application (2020-2025)
Table 12. Global Cyclophosphamide Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cyclophosphamide Revenue Market Share by Application (2020-2025)
Table 14. Global Cyclophosphamide Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Cyclophosphamide Sales by Company (2020-2025) & (Units)
Table 16. Global Cyclophosphamide Sales Market Share by Company (2020-2025)
Table 17. Global Cyclophosphamide Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cyclophosphamide Revenue Market Share by Company (2020-2025)
Table 19. Global Cyclophosphamide Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Cyclophosphamide Producing Area Distribution and Sales Area
Table 21. Players Cyclophosphamide Products Offered
Table 22. Cyclophosphamide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyclophosphamide Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Cyclophosphamide Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cyclophosphamide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cyclophosphamide Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cyclophosphamide Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Cyclophosphamide Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cyclophosphamide Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cyclophosphamide Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cyclophosphamide Sales by Country (2020-2025) & (Units)
Table 34. Americas Cyclophosphamide Sales Market Share by Country (2020-2025)
Table 35. Americas Cyclophosphamide Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 37. Americas Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 38. APAC Cyclophosphamide Sales by Region (2020-2025) & (Units)
Table 39. APAC Cyclophosphamide Sales Market Share by Region (2020-2025)
Table 40. APAC Cyclophosphamide Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 42. APAC Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 43. Europe Cyclophosphamide Sales by Country (2020-2025) & (Units)
Table 44. Europe Cyclophosphamide Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 46. Europe Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Cyclophosphamide Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Cyclophosphamide Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cyclophosphamide Sales byType (2020-2025) & (Units)
Table 50. Middle East & Africa Cyclophosphamide Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Cyclophosphamide
Table 52. Key Market Challenges & Risks of Cyclophosphamide
Table 53. Key IndustryTrends of Cyclophosphamide
Table 54. Cyclophosphamide Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyclophosphamide Distributors List
Table 57. Cyclophosphamide Customer List
Table 58. Global Cyclophosphamide SalesForecast by Region (2026-2031) & (Units)
Table 59. Global Cyclophosphamide RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cyclophosphamide SalesForecast by Country (2026-2031) & (Units)
Table 61. Americas Cyclophosphamide Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cyclophosphamide SalesForecast by Region (2026-2031) & (Units)
Table 63. APAC Cyclophosphamide Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cyclophosphamide SalesForecast by Country (2026-2031) & (Units)
Table 65. Europe Cyclophosphamide RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cyclophosphamide SalesForecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Cyclophosphamide RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Cyclophosphamide SalesForecast byType (2026-2031) & (Units)
Table 69. Global Cyclophosphamide RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Cyclophosphamide SalesForecast by Application (2026-2031) & (Units)
Table 71. Global Cyclophosphamide RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Baxter Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 73. Baxter Cyclophosphamide Product Portfolios and Specifications
Table 74. Baxter Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Baxter Main Business
Table 76. Baxter Latest Developments
Table 77. Novartis Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Cyclophosphamide Product Portfolios and Specifications
Table 79. Novartis Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Hikma Pharmaceuticals Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 83. Hikma Pharmaceuticals Cyclophosphamide Product Portfolios and Specifications
Table 84. Hikma Pharmaceuticals Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Hikma Pharmaceuticals Main Business
Table 86. Hikma Pharmaceuticals Latest Developments
Table 87. Amneal Pharmaceuticals LLC Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 88. Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolios and Specifications
Table 89. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Amneal Pharmaceuticals LLC Main Business
Table 91. Amneal Pharmaceuticals LLC Latest Developments
Table 92. Jiangsu Hengrui Medicine Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 93. Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolios and Specifications
Table 94. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Jiangsu Hengrui Medicine Main Business
Table 96. Jiangsu Hengrui Medicine Latest Developments
Table 97. NorthStar Rx LLC Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 98. NorthStar Rx LLC Cyclophosphamide Product Portfolios and Specifications
Table 99. NorthStar Rx LLC Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. NorthStar Rx LLC Main Business
Table 101. NorthStar Rx LLC Latest Developments
Table 102. GLS Pharma Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 103. GLS Pharma Cyclophosphamide Product Portfolios and Specifications
Table 104. GLS Pharma Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. GLS Pharma Main Business
Table 106. GLS Pharma Latest Developments
Table 107. CSC Pharmaceuticals International Basic Information, Cyclophosphamide Manufacturing Base, Sales Area and Its Competitors
Table 108. CSC Pharmaceuticals International Cyclophosphamide Product Portfolios and Specifications
Table 109. CSC Pharmaceuticals International Cyclophosphamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. CSC Pharmaceuticals International Main Business
Table 111. CSC Pharmaceuticals International Latest Developments
LIST OFFIGURES
Figure 1. Picture of Cyclophosphamide
Figure 2. Cyclophosphamide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclophosphamide Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Cyclophosphamide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cyclophosphamide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cyclophosphamide Sales Market Share by Country/Region (2024)
Figure 10. Cyclophosphamide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of High-Dose
Figure 12. Product Picture of Low-Dose
Figure 13. Global Cyclophosphamide Sales Market Share byType in 2025
Figure 14. Global Cyclophosphamide Revenue Market Share byType (2020-2025)
Figure 15. Cyclophosphamide Consumed in Cancer
Figure 16. Global Cyclophosphamide Market: Cancer (2020-2025) & (Units)
Figure 17. Cyclophosphamide Consumed in Autoimmune Diseases
Figure 18. Global Cyclophosphamide Market: Autoimmune Diseases (2020-2025) & (Units)
Figure 19. Cyclophosphamide Consumed in AL Amyloidosis
Figure 20. Global Cyclophosphamide Market: AL Amyloidosis (2020-2025) & (Units)
Figure 21. Cyclophosphamide Consumed in Others
Figure 22. Global Cyclophosphamide Market: Others (2020-2025) & (Units)
Figure 23. Global Cyclophosphamide Sale Market Share by Application (2024)
Figure 24. Global Cyclophosphamide Revenue Market Share by Application in 2025
Figure 25. Cyclophosphamide Sales by Company in 2025 (Units)
Figure 26. Global Cyclophosphamide Sales Market Share by Company in 2025
Figure 27. Cyclophosphamide Revenue by Company in 2025 ($ millions)
Figure 28. Global Cyclophosphamide Revenue Market Share by Company in 2025
Figure 29. Global Cyclophosphamide Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Cyclophosphamide Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Cyclophosphamide Sales 2020-2025 (Units)
Figure 32. Americas Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 33. APAC Cyclophosphamide Sales 2020-2025 (Units)
Figure 34. APAC Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 35. Europe Cyclophosphamide Sales 2020-2025 (Units)
Figure 36. Europe Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Cyclophosphamide Sales 2020-2025 (Units)
Figure 38. Middle East & Africa Cyclophosphamide Revenue 2020-2025 ($ millions)
Figure 39. Americas Cyclophosphamide Sales Market Share by Country in 2025
Figure 40. Americas Cyclophosphamide Revenue Market Share by Country (2020-2025)
Figure 41. Americas Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 42. Americas Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 43. United States Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Cyclophosphamide Sales Market Share by Region in 2025
Figure 48. APAC Cyclophosphamide Revenue Market Share by Region (2020-2025)
Figure 49. APAC Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 50. APAC Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 51. China Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 55. India Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Cyclophosphamide Sales Market Share by Country in 2025
Figure 59. Europe Cyclophosphamide Revenue Market Share by Country (2020-2025)
Figure 60. Europe Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 61. Europe Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 62. Germany Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 63.France Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Cyclophosphamide Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Cyclophosphamide Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Cyclophosphamide Sales Market Share by Application (2020-2025)
Figure 70. Egypt Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Cyclophosphamide Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Cyclophosphamide in 2025
Figure 76. Manufacturing Process Analysis of Cyclophosphamide
Figure 77. Industry Chain Structure of Cyclophosphamide
Figure 78. Channels of Distribution
Figure 79. Global Cyclophosphamide Sales MarketForecast by Region (2026-2031)
Figure 80. Global Cyclophosphamide Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Cyclophosphamide Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Cyclophosphamide Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Cyclophosphamide Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Cyclophosphamide Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Oxycodone Hydrochloride Market Growth 2025-2031
US$ 3,660.00
March 2025
96 pages
Global Epinephrine Market Growth 2025-2031
US$ 3,660.00
December 2024
111 pages
Global Biomedical Refrigerators Market Growth 2025-2031
US$ 3,660.00
March 2025
136 pages
Global Orthopedic Orthotics Market Growth 2026-2032
US$ 3,660.00
July 2026
185 pages
Global Venous Blood Collection Tube Market Growth 2025-2031
US$ 3,660.00
December 2024
131 pages
